The Evolving Treatment Paradigm of Multiple Myeloma: Insights from Experts at the Cleveland Clinic
Experts from the Cleveland Clinic provide an overview of recent updates in the treatment landscape for patients with multiple myeloma, discussing patient cases, clinical trials, and improving outcomes for patients.
EP: 1.The Evolving Treatment Paradigm of Multiple Myeloma: Insights from Experts at the Cleveland Clinic
EP: 2.Patient Case 1: Transplant-Eligible Newly Diagnosed Multiple Myeloma
EP: 3.Optimal Selection of Therapy for Patients With Transplant-Eligible NDMM
EP: 4.Patient Case 2: Transplant-Ineligible Newly Diagnosed Multiple Myeloma
EP: 5.Treatment Strategies for Patients With Transplant-Ineligible NDMM
EP: 6.Patient Case 3: Relapsed/Refractory Multiple Myeloma
EP: 7.Selecting and Sequencing Bispecifics and CAR-T Therapies in R/R MM
EP: 8.Clinical Practice Perspectives on Treatment of MM with Bispecifics
Recap: Recent Advances in the Treatment of Metastatic Castration-Sensitive Prostate Cancer
September 18th 2022Expert oncologists review key studies in the metastatic castration-resistant prostate cancer treatment landscape and discuss how evidence can be applied to clinical practice to improve patient outcomes.
Recap: Updates in Treatment of HER2-Positive Breast Cancer and Brain Metastases
July 16th 2022Sara A. Hurvitz, MD; Stefania Maraka, MD; and Ruta Rao, MD, discuss the evolving landscape of metastatic HER2+ breast cancer, highlighting recent clinical trials and the management of patients with brain metastases.
Recap: Emory Experts Review Treatment Strategies for Transplant-Ineligible Multiple Myeloma
June 20th 2022A panel of experts from Emory University review several key data updates in multiple myeloma from recent meetings and discuss how the data can be applied to clinical practice to improve patient outcomes.
